{Reference Type}: English Abstract
{Title}: [Breast cancer in men – histopathology and biomarkers].
{Author}: Lokøy IK;Bakken IS;Wik E;Stefansson IM;
{Journal}: Tidsskr Nor Laegeforen
{Volume}: 144
{Issue}: 5
{Year}: 2024 04 23
暂无{DOI}: 10.4045/tidsskr.23.0438
{Abstract}: Breast cancer in men accounts for around 1 % of all cases of the disease. The study aimed to identify histopathological parameters and selected biomarkers in men with breast cancer.<BR>Retrospective study of archival material from 53 men diagnosed with breast cancer at the department of pathology, Haukeland University Hospital, in the period 1996-2020. The prevalence of the oestrogen receptor (ER), progesterone receptor (PGR) and Human Epidermal Growth Factor (HER2) biomarkers was examined.<BR>Median age at time of diagnosis was 72 years. Median tumour diameter was 24 mm. Forty-nine tumours were classified histologically as invasive carcinoma of no special type (NST), 29 tumours were histologic grade 2 and 18 were grade 3. Fifty-two tumours were ER positive, 39 were PGR positive and four were HER2 positive. Twenty-five patients had lymph node metastases.<BR>Our findings indicate that men with breast cancer are diagnosed at an older age than women, and that men have a more advanced stage than women at the time of diagnosis. The histopathology and expression of biomarkers of breast cancer differ between men and women.